Answers are grounded in this paper and cite their sources.
Hepatitis B remains a significant global public health issue, with 296 million people living with chronic infection. Chronic infection can progress to cirrhosis and hepatocellular carcinoma, causing 1.1 million deaths annually. The burden of hepatitis B is particularly high in developing countries, including Iraq, where high rates of vertical transmission contribute to the disease's prevalence. This study evaluates the effectiveness of post-exposure prophylaxis (PEP) against vertical transmission of hepatitis B in Duhok city, Kurdistan region of Iraq. A total of 44 pregnant women with chronic hepatitis B were included. All infants received hepatitis B immune globulin (HBIG) within 24 hours of birth, followed by the hepatitis B vaccine at birth, 2, and 6 months of age. At 7 months, none of the infants tested positive for HBsAg, and all demonstrated protective levels of hepatitis B surface antibodies (HBsAb >100 IU/L). These findings indicate a high success rate of the implemented PEP regimen and endorse the continued use of PEP as an effective strategy for preventing vertical transmission of hepatitis B and providing strong immunity in the infants. Future study should further investigate the effectiveness of additional preventive measures and calls for broader implementation of similar protocols in other regions.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: